Overview

Enoxaparin in Acute Venous Thromboembolic Disease

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Study objectives : - To evaluate the efficacy/safety profile of enoxaparin once a day treatment in acute venous thromboembolic disease.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Enoxaparin